Published in Brain Res on July 06, 2007
Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab (2010) 1.44
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem (2008) 1.22
The annexin A2 system and vascular homeostasis. Vascul Pharmacol (2011) 1.14
Arterial spin labeling and dynamic susceptibility contrast CBF MRI in postischemic hyperperfusion, hypercapnia, and after mannitol injection. J Cereb Blood Flow Metab (2010) 1.02
Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy. Stroke (2010) 0.98
Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2. J Biol Chem (2010) 0.96
The annexin A2/S100A10 system in health and disease: emerging paradigms. J Biomed Biotechnol (2012) 0.96
Annexin A2 system in human biology: cell surface and beyond. Semin Thromb Hemost (2013) 0.92
Visualization of clot lysis in a rat embolic stroke model: application to comparative lytic efficacy. Stroke (2011) 0.91
Anti-annexin II antibody is associated with thrombosis and/or pregnancy morbidity in antiphospholipid syndrome and systemic lupus erythematosus with thrombosis. Rheumatol Int (2010) 0.91
The endothelial cell annexin A2 system and vascular fibrinolysis. Gen Physiol Biophys (2009) 0.88
Stroke neuroprotection: targeting mitochondria. Brain Sci (2013) 0.80
The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity. Trans Am Clin Climatol Assoc (2015) 0.80
Effects of stroke severity and treatment duration in normobaric hyperoxia treatment of ischemic stroke. Brain Res (2016) 0.76
Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med (1995) 47.15
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) JAMA (1995) 13.37
Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci (1999) 10.61
A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab (1990) 8.26
Thresholds in cerebral ischemia - the ischemic penumbra. Stroke (1982) 5.20
Viability thresholds and the penumbra of focal ischemia. Ann Neurol (1994) 4.49
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest (2003) 3.41
Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med (2003) 3.10
Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke (1999) 2.85
An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem (1994) 2.22
Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol (2004) 2.14
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med (1990) 2.09
Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke (2003) 1.93
The neurotoxicity of tissue plasminogen activator? J Cereb Blood Flow Metab (2004) 1.80
Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia. Stroke (2005) 1.77
Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci (2002) 1.66
Dynamic tracking of acute ischemic tissue fates using improved unsupervised ISODATA analysis of high-resolution quantitative perfusion and diffusion data. J Cereb Blood Flow Metab (2004) 1.52
Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging. J Cereb Blood Flow Metab (2004) 1.49
Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3. Stroke (2003) 1.32
Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res (1997) 1.23
Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. J Biol Chem (2004) 1.16
Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group. Stroke (1999) 1.12
Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: relevance of interactions between thrombotic material and thrombolytic agent. Vascul Pharmacol (2005) 1.10
Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging (1999) 1.09
Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery. Circ Res (2001) 1.09
New method of embolus preparation for standardized embolic stroke in rabbits. Stroke (2002) 1.09
Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. J Biol Chem (1990) 1.08
The endothelial cell tissue plasminogen activator receptor. Specific interaction with plasminogen. J Biol Chem (1991) 1.00
Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res (2000) 0.98
A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab (1992) 0.98
Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging. J Cereb Blood Flow Metab (1998) 0.97
Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model. Stroke (2001) 0.95
Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: the modulating effect of statins. Atherosclerosis (2005) 0.93
Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging. J Cereb Blood Flow Metab (2001) 0.92
Histopathologic correlates of temporal diffusion changes in a rat model of cerebral hypoxia/ischemia. AJNR Am J Neuroradiol (2000) 0.82
Dissolution of emboli in rats with experimental cerebral thromboembolism by recombinant human tissue plasminogen activator (TD-2061). Thromb Res (1990) 0.78
Serial thrombolysis-related changes after thrombolytic therapy with TPA in patients with acute myocardial infarction. Thromb Res (1990) 0.77
Recovery of apparent diffusion coefficient after embolic stroke does not signify complete salvage of post-ischemic neuronal tissue. Acta Neurochir Suppl (2003) 0.76
Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy. J Neurosurg (2013) 3.39
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity (2008) 3.11
Molecular mechanisms of fibrinolysis. Br J Haematol (2005) 3.03
Effects of hypoxia, hyperoxia, and hypercapnia on baseline and stimulus-evoked BOLD, CBF, and CMRO2 in spontaneously breathing animals. Neuroimage (2005) 2.59
Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab (2003) 2.52
Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest (2004) 2.45
Origin of negative blood oxygenation level-dependent fMRI signals. J Cereb Blood Flow Metab (2002) 2.34
Pixel-by-pixel spatiotemporal progression of focal ischemia derived using quantitative perfusion and diffusion imaging. J Cereb Blood Flow Metab (2003) 2.34
Structural and functional MRI reveals multiple retinal layers. Proc Natl Acad Sci U S A (2006) 2.15
Characterizing the diffusion/perfusion mismatch in experimental focal cerebral ischemia. Ann Neurol (2004) 2.14
Imaging oxygen consumption in forepaw somatosensory stimulation in rats under isoflurane anesthesia. Magn Reson Med (2004) 2.12
Spin-echo fMRI in humans using high spatial resolutions and high magnetic fields. Magn Reson Med (2003) 2.06
Retracted Apolipoprotein CIII links hyperlipidemia with vascular endothelial cell dysfunction. Circulation (2008) 2.04
Functional, perfusion and diffusion MRI of acute focal ischemic brain injury. J Cereb Blood Flow Metab (2005) 2.01
Simplified laser-speckle-imaging analysis method and its application to retinal blood flow imaging. Opt Lett (2007) 1.96
Procedure for minimizing stress for fMRI studies in conscious rats. J Neurosci Methods (2005) 1.85
Retracted Toll-like receptor 2 mediates apolipoprotein CIII-induced monocyte activation. Circ Res (2008) 1.85
Trigeminal neuralgia: evaluation of neuralgic manifestation and site of neurovascular compression with 3D CISS MR imaging and MR angiography. Radiology (2003) 1.76
Trigeminal neuralgia associated with a primitive trigeminal artery variant: case report. Neurosurgery (2003) 1.74
Temporal statistical analysis of laser speckle images and its application to retinal blood-flow imaging. Opt Express (2008) 1.70
An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem (2004) 1.68
Yin Yang-1 inhibits vascular smooth muscle cell growth and intimal thickening by repressing p21WAF1/Cip1 transcription and p21WAF1/Cip1-Cdk4-cyclin D1 assembly. Circ Res (2007) 1.67
Myelination and long diffusion times alter diffusion-tensor-imaging contrast in myelin-deficient shiverer mice. Neuroimage (2005) 1.64
Equilibrium water exchange between the intra- and extracellular spaces of mammalian brain. Magn Reson Med (2003) 1.58
A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke (2007) 1.58
Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease. J Leukoc Biol (2013) 1.57
Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett (2007) 1.55
Preoperative evaluation of neurovascular compression in patients with trigeminal neuralgia by use of three-dimensional reconstruction from two types of high-resolution magnetic resonance imaging. Neurosurgery (2002) 1.53
Dynamic tracking of acute ischemic tissue fates using improved unsupervised ISODATA analysis of high-resolution quantitative perfusion and diffusion data. J Cereb Blood Flow Metab (2004) 1.52
Effects of reperfusion on ADC and CBF pixel-by-pixel dynamics in stroke: characterizing tissue fates using quantitative diffusion and perfusion imaging. J Cereb Blood Flow Metab (2004) 1.49
Dietary acid intake and kidney disease progression in the elderly. Am J Nephrol (2014) 1.48
Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood (2013) 1.48
Annexin II: a plasminogen-plasminogen activator co-receptor. Front Biosci (2002) 1.47
Transvenous embolization for a purely intraorbital arteriovenous fistula. Case report. J Neurosurg (2005) 1.45
Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke. J Cereb Blood Flow Metab (2010) 1.44
Nonlinear coupling between cerebral blood flow, oxygen consumption, and ATP production in human visual cortex. Proc Natl Acad Sci U S A (2010) 1.44
Increased levels of tissue endostatin in human malignant gliomas. Clin Cancer Res (2002) 1.43
Combination of amlodipine and atorvastatin synergistically reduces leukocyte recruitment to mechanically injured mouse femoral artery. Hypertens Res (2011) 1.41
STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol (2014) 1.41
Use of 5-aminolevulinic acid in fluorescence-guided resection of meningioma with high risk of recurrence. Case report. J Neurosurg (2007) 1.36
Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome. Blood (2006) 1.34
Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines. J Biol Chem (2002) 1.33
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood (2003) 1.32
Blood-flow magnetic resonance imaging of the retina. Neuroimage (2007) 1.30
Human neural stem/progenitor cells, expanded in long-term neurosphere culture, promote functional recovery after focal ischemia in Mongolian gerbils. J Neurosci Res (2004) 1.30
Statistical prediction of tissue fate in acute ischemic brain injury. J Cereb Blood Flow Metab (2005) 1.30
The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol (2011) 1.30
Tauopathy with paired helical filaments in an aged chimpanzee. J Comp Neurol (2008) 1.27
Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes. Invest Ophthalmol Vis Sci (2012) 1.26
Apolipoprotein CIII links dyslipidemia with atherosclerosis. J Atheroscler Thromb (2009) 1.26
Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol (2006) 1.24
Magnetic resonance imaging of tissue and vascular layers in the cat retina. J Magn Reson Imaging (2006) 1.24
MRI of retinal and choroidal blood flow with laminar resolution. NMR Biomed (2010) 1.24
Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg (2003) 1.24
Annexin A2 promotes glioma cell invasion and tumor progression. J Neurosci (2011) 1.23
Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11. J Biol Chem (2008) 1.22
Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int J Oncol (2006) 1.22
Hemodynamic and metabolic changes induced by cocaine in anesthetized rat observed with multimodal functional MRI. Psychopharmacology (Berl) (2006) 1.21
Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases. J Neurooncol (2010) 1.21
Spatiotemporal dynamics of diffusional kurtosis, mean diffusivity and perfusion changes in experimental stroke. Brain Res (2012) 1.20
Managing subdural fluid collection in infants. Childs Nerv Syst (2002) 1.18
Cerebral blood flow MRI in mice using the cardiac-spin-labeling technique. Magn Reson Med (2008) 1.18
Transcranial imaging of functional cerebral hemodynamic changes in single blood vessels using in vivo photoacoustic microscopy. J Cereb Blood Flow Metab (2012) 1.18
Lamina-specific functional MRI of retinal and choroidal responses to visual stimuli. Invest Ophthalmol Vis Sci (2011) 1.18
Blood flow magnetic resonance imaging of retinal degeneration. Invest Ophthalmol Vis Sci (2008) 1.18
Intensity of chronic cerebral hypoperfusion determines white/gray matter injury and cognitive/motor dysfunction in mice. J Neurosci Res (2009) 1.18
Imaging cocaine-induced changes in the mesocorticolimbic dopaminergic system of conscious rats. J Neurosci Methods (2004) 1.17
Echo-planar BOLD fMRI of mice on a narrow-bore 9.4 T magnet. Magn Reson Med (2004) 1.17
Methylene blue is neuroprotective against mild traumatic brain injury. J Neurotrauma (2014) 1.17
Boron neutron capture therapy for newly diagnosed glioblastoma. J Radiat Res (2008) 1.16
Malignant transformation eight years after removal of a benign epidermoid cyst: a case report. J Neurooncol (2006) 1.16
Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance. Am J Physiol Endocrinol Metab (2009) 1.15
The annexin A2 system and vascular homeostasis. Vascul Pharmacol (2011) 1.14
The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology (2005) 1.14
Layer-specific functional and anatomical MRI of the retina with passband balanced SSFP. Magn Reson Med (2011) 1.13
Activation of neural pathways associated with sexual arousal in non-human primates. J Magn Reson Imaging (2004) 1.13
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood (2009) 1.13
Methylene blue as a cerebral metabolic and hemodynamic enhancer. PLoS One (2012) 1.12
Spatiotemporal characteristics of postischemic hyperperfusion with respect to changes in T1, T2, diffusion, angiography, and blood-brain barrier permeability. J Cereb Blood Flow Metab (2011) 1.12
MRI of blood flow of the human retina. Magn Reson Med (2011) 1.12
Quantitative prediction of ischemic stroke tissue fate. NMR Biomed (2008) 1.12
FMRI of brain activation in a genetic rat model of absence seizures. Epilepsia (2004) 1.11
Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke (2005) 1.11
Blood oxygenation level-dependent (BOLD) functional MRI of visual stimulation in the rat retina at 11.7 T. NMR Biomed (2010) 1.09
Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas. J Neurooncol (2008) 1.09
CBF, BOLD, CBV, and CMRO(2) fMRI signal temporal dynamics at 500-msec resolution. J Magn Reson Imaging (2008) 1.09
Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: an efficacy study based on findings on neuroimages. J Neurosurg (2005) 1.09
Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg (2005) 1.09
Methylene blue potentiates stimulus-evoked fMRI responses and cerebral oxygen consumption during normoxia and hypoxia. Neuroimage (2013) 1.08
Intraosseous malignant peripheral nerve sheath tumor with focal epithelioid differentiation of the thoracic spine. Neurol India (2007) 1.08
Neuroprotective efficacy of methylene blue in ischemic stroke: an MRI study. PLoS One (2013) 1.07
Quantitative basal CBF and CBF fMRI of rhesus monkeys using three-coil continuous arterial spin labeling. Neuroimage (2006) 1.07